Nanopublications LDF server

Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06643_nanopub.RA_Fq60Ze7JRATMhVCK1TztIf-VCHxd7KIE14Ew13NDkg#assertion>. }

• drugbank:DB06643 type drugbank_vocabulary:Drug assertion.
• drugbank:DB06643 label "Denosumab [drugbank:DB06643]" assertion.
• drugbank:DB06643 seeAlso DB06643 assertion.
• drugbank:DB06643 seeAlso denosumab.html assertion.
• drugbank:DB06643 seeAlso prolia-drug.htm assertion.
• drugbank:DB06643 identifier "drugbank:DB06643" assertion.
• drugbank:DB06643 description "Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides. FDA approved on June 1, 2010." assertion.
• drugbank:DB06643 title "Denosumab" assertion.
• drugbank:DB06643 bio2rdf_vocabulary:identifier "DB06643" assertion.
• drugbank:DB06643 bio2rdf_vocabulary:namespace "drugbank" assertion.
• drugbank:DB06643 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06643" assertion.
• drugbank:DB06643 bio2rdf_vocabulary:x-identifiers.org DB06643 assertion.
• drugbank:DB06643 drugbank_vocabulary:drugbank-id "DB06643" assertion.
• drugbank:DB06643 drugbank_vocabulary:x-cas cas:615258-40-7 assertion.
• drugbank:DB06643 drugbank_vocabulary:x-ahfs ahfs:92:24 assertion.
• drugbank:DB06643 drugbank_vocabulary:x-atc atc:M05BX04 assertion.
• drugbank:DB06643 drugbank_vocabulary:x-kegg kegg:D03684 assertion.
• drugbank:DB06643 drugbank_vocabulary:x-pharmgkb pharmgkb:PA166048634 assertion.
• drugbank:DB06643 drugbank_vocabulary:x-wikipedia wikipedia:Denosumab assertion.
• drugbank:DB06643 drugbank_vocabulary:x-ndc ndc:55513-710-01 assertion.